Home LiteratureArticle Details
PMID: 18725826 Published · ppublish English Journal Article Review

Implications of new colorectal cancer screening technologies for primary care practice.

Medical care ·Vol. 46 ·No. 9 Suppl 1 ·2008-09-00 ·Pages S138-46

Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF, Brown ML

Abstract

暂无摘要

MeSH Terms
Colon/diagnostic imaging Colonography, Computed Tomographic/methods Colonoscopy/methods Colorectal Neoplasms/diagnosis,prevention & control DNA, Neoplasm/analysis Feces/chemistry Humans Mass Screening/methods,trends Occult Blood Primary Health Care/trends Risk Assessment/methods Sigmoidoscopy/methods United States/epidemiology
Chemicals
DNA, Neoplasm
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Zauber Ann G
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. zaubera@mskcc.org
Levin Theodore R
Jaffe C Carl
Galen Barbara A
Ransohoff David F
Brown Martin L
References (64)
64 references, click to expand
  1. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer.
    Ann Intern Med. 2003 Dec 16;139(12):959-65 PMID: 14678915
  2. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    J Natl Cancer Inst. 1999 Mar 3;91(5):434-7 PMID: 10070942
  3. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group.
    N Engl J Med. 2000 Jun 15;342(24):1766-72 PMID: 10852998
  4. Fecal occult blood test--the importance of proper evaluation.
    J Clin Gastroenterol. 1990 Aug;12(4):393-5 PMID: 2398247
  5. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions.
    J Gen Intern Med. 2007 Aug;22(8):1195-205 PMID: 17534688
  6. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
    Science. 1992 Apr 3;256(5053):102-5 PMID: 1566048
  7. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.
    CA Cancer J Clin. 2001 Jan-Feb;51(1):38-75; quiz 77-80 PMID: 11577479
  8. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.
    N Engl J Med. 1993 Dec 30;329(27):1977-81 PMID: 8247072
  9. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Gastroenterology. 2005 Aug;129(2):422-8 PMID: 16083699
  10. Detecting K-ras mutations in stool from fecal occult blood test cards in multiphasic screening for colorectal cancer.
    Cancer Lett. 2007 Aug 18;253(2):258-64 PMID: 17349741
  11. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
    JAMA. 1999 May 5;281(17):1611-7 PMID: 10235154
  12. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
    Lancet. 1996 Nov 30;348(9040):1467-71 PMID: 8942774
  13. Colorectal cancer screening: clinical guidelines and rationale.
    Gastroenterology. 1997 Feb;112(2):594-642 PMID: 9024315
  14. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70 PMID: 17895475
  15. Failure of health care professionals to interpret fecal occult blood tests accurately.
    Am J Med. 2003 Jan;114(1):64-7 PMID: 12543293
  16. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer.
    J Cell Biochem Suppl. 2000;34:35-9 PMID: 10762013
  17. Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group.
    Ann Intern Med. 1991 May 15;114(10):875-6 PMID: 2014949
  18. Colonoscopic screening of average-risk women for colorectal neoplasia.
    N Engl J Med. 2005 May 19;352(20):2061-8 PMID: 15901859
  19. Improved fecal DNA test for colorectal cancer screening.
    Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7 PMID: 17161655
  20. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):389-94 PMID: 16492934
  21. A comparison of fecal occult-blood tests for colorectal-cancer screening.
    N Engl J Med. 1996 Jan 18;334(3):155-9 PMID: 8531970
  22. Colorectal cancer in African Americans.
    Am J Gastroenterol. 2005 Mar;100(3):515-23; discussion 514 PMID: 15743345
  23. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
    Gastroenterology. 2006 May;130(6):1872-85 PMID: 16697750
  24. Detecting colorectal cancer in stool with the use of multiple genetic targets.
    J Natl Cancer Inst. 2001 Jun 6;93(11):858-65 PMID: 11390535
  25. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.
    N Engl J Med. 1993 Apr 1;328(13):901-6 PMID: 8446136
  26. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
    Ann Intern Med. 2007 Feb 20;146(4):244-55 PMID: 17310048
  27. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.
    N Engl J Med. 2006 Nov 2;355(18):1863-72 PMID: 17079760
  28. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
    Clin Chem. 2007 Sep;53(9):1646-51 PMID: 17712002
  29. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.
    Clin Colorectal Cancer. 2003 May;3(1):47-53 PMID: 12777192
  30. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.
    Gastroenterology. 2000 Nov;119(5):1219-27 PMID: 11054379
  31. Computed tomography--an increasing source of radiation exposure.
    N Engl J Med. 2007 Nov 29;357(22):2277-84 PMID: 18046031
  32. Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer: a feasibility study.
    Clin Chem. 2004 Nov;50(11):2179-82 PMID: 15502094
  33. Complications of colonoscopy in an integrated health care delivery system.
    Ann Intern Med. 2006 Dec 19;145(12):880-6 PMID: 17179057
  34. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test.
    J Mol Diagn. 2004 Nov;6(4):386-95 PMID: 15507679
  35. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer.
    Am J Gastroenterol. 2002 Jun;97(6):1296-308 PMID: 12094842
  36. Detection of APC mutations in fecal DNA from patients with colorectal tumors.
    N Engl J Med. 2002 Jan 31;346(5):311-20 PMID: 11821507
  37. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
    Gastroenterology. 2004 Dec;127(6):1661-9 PMID: 15578502
  38. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
    N Engl J Med. 1993 May 13;328(19):1365-71 PMID: 8474513
  39. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Cancer. 2006 Nov 1;107(9):2152-9 PMID: 16998938
  40. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    N Engl J Med. 2000 Nov 30;343(22):1603-7 PMID: 11096167
  41. A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.
    N Engl J Med. 2004 Dec 23;351(26):2755-8 PMID: 15616212
  42. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults.
    JAMA. 2008 Mar 5;299(9):1027-35 PMID: 18319413
  43. Modern endoscopy of the alimentary tract.
    Curr Probl Surg. 1974 Jan;:1-62 PMID: 4593571
  44. Effect of physician recommendation and patient adherence on rates of colorectal cancer testing.
    Cancer Detect Prev. 2004;28(4):260-8 PMID: 15350629
  45. American Cancer Society guidelines for the early detection of cancer, 2003.
    CA Cancer J Clin. 2003 Jan-Feb;53(1):27-43 PMID: 12568442
  46. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.
    Am J Gastroenterol. 2005 Oct;100(10):2274-9 PMID: 16181380
  47. Genetic alterations during colorectal-tumor development.
    N Engl J Med. 1988 Sep 1;319(9):525-32 PMID: 2841597
  48. Screening for colorectal cancer: recommendation and rationale.
    Ann Intern Med. 2002 Jul 16;137(2):129-31 PMID: 12118971
  49. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.
    Nat Genet. 1997 Sep;17(1):79-83 PMID: 9288102
  50. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy.
    N Engl J Med. 2006 Dec 14;355(24):2533-41 PMID: 17167136
  51. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    N Engl J Med. 2004 Dec 23;351(26):2704-14 PMID: 15616205
  52. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.
    N Engl J Med. 2000 Jul 20;343(3):169-74 PMID: 10900275
  53. A call to action--measuring the quality of colonoscopy.
    N Engl J Med. 2006 Dec 14;355(24):2588-9 PMID: 17167143
  54. A widely applicable protocol for DNA isolation from fecal samples.
    Biochem Genet. 2006 Dec;44(11-12):503-12 PMID: 17094033
  55. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
    J Natl Cancer Inst. 2005 Aug 3;97(15):1124-32 PMID: 16077070
  56. American Cancer Society guidelines for the early detection of cancer, 2006.
    CA Cancer J Clin. 2006 Jan-Feb;56(1):11-25; quiz 49-50 PMID: 16449183
  57. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.
    N Engl J Med. 2003 Dec 4;349(23):2191-200 PMID: 14657426
  58. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1115-9 PMID: 16775168
  59. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Lancet. 1996 Nov 30;348(9040):1472-7 PMID: 8942775
  60. Molecular basis for stool-based DNA tests for colorectal cancer: a primer for clinicians.
    Rev Gastroenterol Disord. 2002;2 Suppl 1:S12-9 PMID: 12439394
  61. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Am J Gastroenterol. 2007 May;102(5):1070-6 PMID: 17378912
  62. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.
    Gastroenterology. 2003 Feb;124(2):544-60 PMID: 12557158
  63. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
    CA Cancer J Clin. 2008 May-Jun;58(3):130-60 PMID: 18322143
  64. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.
    N Engl J Med. 2000 Jul 20;343(3):162-8 PMID: 10900274
Article Info
Journal
Medical care
Abbr.
Med Care
ISSN
1537-1948
DOI
10.1097/MLR.0b013e31818192ef
Email
zaubera@mskcc.org
Published
2008-09-00
Pages
S138-46
Language
English
Region
United States
NLM ID
0230027
PMCID
PMC4854519
Subset
IM
Grants
NCI NIH HHS · U01 CA097426 · United States
External Links
PubMed source DOI: 10.1097/MLR.0b013e31818192ef PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2